Literature DB >> 18691500

Circulating tissue factor-exposing microparticles.

Daniel Lechner1, Ansgar Weltermann.   

Abstract

Upon stimulation or apoptosis, eukaryotic cells shed membrane vesicles of submicron size. These so-called microparticles (MPs) are detected and characterized based on the exposure of antigens characteristic of their respective parental cells and on the increased distribution of negatively charged phospholipids to the outer membrane layer. Among the various hypothesized functions of MPs in both health and disease, one of the most studied is their possible role in hemostasis and thrombosis. In this context, special attention is paid to tissue factor (TF) exposed on a variety of MPs. MPs may have outstanding functional because of their ability to display "active" TF due to an abundance of negatively charged phospholipids on their surface. The rapid accumulation of TF-bearing MPs (TF+MPs) in a developing thrombus as well as the increased numbers and thrombogenic activity of TF+MPs in prothrombotic disorders indicate an important role in the pathogenesis of thrombosis. Nevertheless, isolation, quantification and antigenic characterization of TF+MPs proved challenging and a lively scientific debate is ongoing with respect to a reliable method to determine the cellular source of MP in vivo. Standardization of preanalytical procedures and development of more sensitive technologies are needed to improve our current understanding of the role of circulating TF+MPs in thrombosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691500     DOI: 10.1016/S0049-3848(08)70019-7

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  18 in total

Review 1.  Thrombogenesis in atrial fibrillation contributing mechanisms and natural history.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2009-01-28       Impact factor: 2.300

2.  Thrombogenesis in atrial fibrillation: contributing mechanisms and natural history.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-10-19       Impact factor: 2.300

Review 3.  Infusible platelet membrane as a platelet substitute for transfusion: an overview.

Authors:  Saleh Nasiri
Journal:  Blood Transfus       Date:  2013-05-14       Impact factor: 3.443

4.  Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity.

Authors:  R D Lee; D A Barcel; J C Williams; J G Wang; J C Boles; D A Manly; N S Key; N Mackman
Journal:  Thromb Res       Date:  2011-07-06       Impact factor: 3.944

Review 5.  Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation.

Authors:  Florian Langer; Wolfram Ruf
Journal:  Thromb Haemost       Date:  2014-01-23       Impact factor: 5.249

Review 6.  Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis.

Authors:  Giovanni Cimmino; Plinio Cirillo
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

Review 7.  Analysis of tissue factor positive microparticles.

Authors:  Nigel S Key
Journal:  Thromb Res       Date:  2010-02-26       Impact factor: 3.944

Review 8.  Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited?

Authors:  Giovanni Cimmino; Paolo Golino; Juan Jose Badimon
Journal:  Intern Emerg Med       Date:  2010-07-07       Impact factor: 3.397

9.  Paracrine induction of endothelium by tumor exosomes.

Authors:  Joshua L Hood; Hua Pan; Gregory M Lanza; Samuel A Wickline
Journal:  Lab Invest       Date:  2009-09-28       Impact factor: 5.662

10.  C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood.

Authors:  A Landsem; E W Nielsen; H Fure; D Christiansen; J K Ludviksen; J D Lambris; B Østerud; T E Mollnes; O-L Brekke
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.